Magnus Ekelund

1.1k total citations
30 papers, 675 citations indexed

About

Magnus Ekelund is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Magnus Ekelund has authored 30 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Surgery and 11 papers in Genetics. Recurrent topics in Magnus Ekelund's work include Diabetes Management and Research (20 papers), Diabetes Treatment and Management (12 papers) and Pancreatic function and diabetes (12 papers). Magnus Ekelund is often cited by papers focused on Diabetes Management and Research (20 papers), Diabetes Treatment and Management (12 papers) and Pancreatic function and diabetes (12 papers). Magnus Ekelund collaborates with scholars based in Sweden, Denmark and United States. Magnus Ekelund's co-authors include Kerstin Berntorp, Nael Shaat, P. Almgren, L. Groop, Marcus Lind, Leif Groop, Sofia Dahlqvist, Irl B. Hirsch, Markku Lehto and Jianping Weng and has published in prestigious journals such as Diabetes Care, Diabetes and BMJ.

In The Last Decade

Magnus Ekelund

29 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magnus Ekelund Sweden 14 375 297 243 184 101 30 675
Chris Vercammen Belgium 15 441 1.2× 418 1.4× 297 1.2× 266 1.4× 110 1.1× 24 823
Nael Shaat Sweden 16 298 0.8× 350 1.2× 619 2.5× 204 1.1× 297 2.9× 27 909
Rossana Román Chile 12 313 0.8× 157 0.5× 31 0.1× 163 0.9× 71 0.7× 38 491
Victoria Núñez United States 6 142 0.4× 79 0.3× 130 0.5× 103 0.6× 62 0.6× 9 407
A. Watts United Kingdom 11 234 0.6× 100 0.3× 55 0.2× 101 0.5× 127 1.3× 13 503
T. Schill Germany 15 136 0.4× 98 0.3× 94 0.4× 52 0.3× 45 0.4× 19 880
Francisca Eyzaguirre Chile 11 184 0.5× 55 0.2× 71 0.3× 45 0.2× 71 0.7× 15 543
Jorge Dores Portugal 11 102 0.3× 109 0.4× 109 0.4× 29 0.2× 54 0.5× 43 330
Carolien Moyson Belgium 11 91 0.2× 185 0.6× 261 1.1× 25 0.1× 99 1.0× 15 377
Anne Bush United Kingdom 7 307 0.8× 29 0.1× 100 0.4× 44 0.2× 97 1.0× 9 1.2k

Countries citing papers authored by Magnus Ekelund

Since Specialization
Citations

This map shows the geographic impact of Magnus Ekelund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Ekelund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Ekelund more than expected).

Fields of papers citing papers by Magnus Ekelund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnus Ekelund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Ekelund. The network helps show where Magnus Ekelund may publish in the future.

Co-authorship network of co-authors of Magnus Ekelund

This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Ekelund. A scholar is included among the top collaborators of Magnus Ekelund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Ekelund. Magnus Ekelund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirsch, Irl B., et al.. (2021). Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections. Diabetes Technology & Therapeutics. 23(6). 425–433. 3 indexed citations
2.
Gorst‐Rasmussen, Anders, Jeppe Sturis, & Magnus Ekelund. (2021). Continuous Glucose Monitoring Sensor Glucose Levels and Insulin Pump Infusion Set Wear-Time During Treatment with Fast-Acting Insulin Aspart: A Post Hoc Analysis of Onset 5. Diabetes Technology & Therapeutics. 24(1). 10–17. 3 indexed citations
3.
Russell, Steven J., COURTNEY A. BALLIRO, Magnus Ekelund, et al.. (2021). Improvements in Glycemic Control Achieved by Altering the tmax Setting in the iLet® Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial. Diabetes Therapy. 12(7). 2019–2033. 11 indexed citations
4.
Ekelund, Magnus, et al.. (2020). A survey of physician experience and treatment satisfaction using fast-acting insulin aspart in people with type 1 or type 2 diabetes. Postgraduate Medicine. 132(4). 320–327. 7 indexed citations
5.
6.
Ólafsdóttir, Arndís F., Jan Bolinder, Tim Heise, et al.. (2020). The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial ( GOLD‐5 ). Diabetes Obesity and Metabolism. 23(2). 619–630. 8 indexed citations
7.
Bode, Bruce W., Violeta Iotova, М. А. Коваренко, et al.. (2019). Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial. Diabetes Care. 42(7). 1255–1262. 46 indexed citations
8.
Imberg, Henrik, Arndís F. Ólafsdóttir, Magnus Ekelund, et al.. (2019). Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections. Diabetes Therapy. 10(6). 2115–2130. 16 indexed citations
9.
Rose, Ludger, Takashi Kadowaki, Thomas R. Pieber, et al.. (2019). Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials. Diabetes Therapy. 10(3). 1029–1041. 3 indexed citations
10.
Battelino, Tadej, Larry C. Deeb, Magnus Ekelund, et al.. (2018). Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial. Pediatric Diabetes. 19(7). 1263–1270. 10 indexed citations
11.
12.
13.
Ekelund, Magnus, et al.. (2016). Model for individual prediction of diabetes up to 5 years after gestational diabetes mellitus. SpringerPlus. 5(1). 318–318. 6 indexed citations
14.
Lind, Marcus, Irl B. Hirsch, Jaakko Tuomilehto, et al.. (2015). Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial). BMJ. 351. h5364–h5364. 60 indexed citations
15.
Ekelund, Magnus, et al.. (2014). Role of HbA1c in post-partum screening of women with gestational diabetes mellitus. Journal of Clinical & Translational Endocrinology. 2(1). 21–25. 19 indexed citations
16.
Ekelund, Magnus, Lotus Mallbris, S Qvitzau, & B Stenberg. (2013). A Higher Score on the Dermatology Life Quality Index, Being on Systemic Treatment and Having a Diagnosis of Psoriatic Arthritis is Associated with Increased Costs in Patients with Plaque Psoriasis. Acta Dermato Venereologica. 93(6). 684–688. 18 indexed citations
17.
Shaat, Nael, et al.. (2013). The impact of ethnicity on glucose homeostasis after gestational diabetes mellitus. Acta Diabetologica. 50(6). 927–934. 25 indexed citations
18.
Ekelund, Magnus, Nael Shaat, P. Almgren, et al.. (2012). Genetic prediction of postpartum diabetes in women with gestational diabetes mellitus. Diabetes Research and Clinical Practice. 97(3). 394–398. 35 indexed citations
19.
Ivarsson, Sten A., Å. Nilsson, Roland Perfekt, et al.. (2004). Genotypic and phenotypic differences between Arabian and Scandinavian women with gestational diabetes mellitus. Diabetologia. 47(5). 878–884. 48 indexed citations
20.
Weng, Jianping, Magnus Ekelund, Markku Lehto, et al.. (2002). Screening for MODY Mutations, GAD Antibodies, and Type 1 Diabetes– Associated HLA Genotypes in Women With Gestational Diabetes Mellitus. Diabetes Care. 25(1). 68–71. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Vercammen Breakdown of academic impact, for papers by Nael Shaat Breakdown of academic impact, for papers by Rossana Román Breakdown of academic impact, for papers by Victoria Núñez Breakdown of academic impact, for papers by A. Watts Breakdown of academic impact, for papers by T. Schill Breakdown of academic impact, for papers by Francisca Eyzaguirre Breakdown of academic impact, for papers by Jorge Dores Breakdown of academic impact, for papers by Carolien Moyson Breakdown of academic impact, for papers by Anne Bush
Rankless by CCL
2026